2012 Q4 Form 10-Q Financial Statement

#000005947812000021 Filed on October 26, 2012

View on sec.gov

Income Statement

Concept 2012 Q4 2012 Q3 2011 Q3
Revenue $5.957B $5.443B $6.148B
YoY Change -1.48% -11.46% 8.72%
Cost Of Revenue $1.248B $1.204B $1.338B
YoY Change -5.55% -10.05% 35.49%
Gross Profit $4.709B $4.240B $4.810B
YoY Change -0.34% -11.85% 3.06%
Gross Profit Margin 79.05% 77.89% 78.23%
Selling, General & Admin $1.978B $1.757B $1.918B
YoY Change -7.31% -8.36% 13.15%
% of Gross Profit 41.99% 41.45% 39.87%
Research & Development $1.463B $1.343B $1.281B
YoY Change 7.95% 4.83% 5.01%
% of Gross Profit 31.07% 31.67% 26.63%
Depreciation & Amortization $344.6M $369.7M $358.2M
YoY Change 8.06% 3.21% 3.92%
% of Gross Profit 7.32% 8.72% 7.45%
Operating Expenses $3.441B $3.100B $3.199B
YoY Change -1.38% -3.08% 9.74%
Operating Profit $1.268B $1.140B $1.611B
YoY Change 2.6% -29.27% -8.07%
Interest Expense -$16.50M $47.00M $45.00M
YoY Change -35.8% 4.44% -245.63%
% of Operating Profit -1.3% 4.12% 2.79%
Other Income/Expense, Net -$52.00M $788.5M -$83.40M
YoY Change 4627.27% -1045.44% -1006.52%
Pretax Income $1.012B $1.875B $1.503B
YoY Change -2.82% 24.77% -10.1%
Income Tax $185.2M $548.1M $266.2M
% Of Pretax Income 18.29% 29.24% 17.72%
Net Earnings $827.2M $1.327B $1.236B
YoY Change -3.61% 7.3% -5.11%
Net Earnings / Revenue 13.89% 24.37% 20.11%
Basic Earnings Per Share $0.75 $1.18
Diluted Earnings Per Share $0.74 $1.18 $1.110M
COMMON SHARES
Basic Shares Outstanding 1.160B shares 1.160B shares
Diluted Shares Outstanding

Balance Sheet

Concept 2012 Q4 2012 Q3 2011 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.684B $6.900B $6.784B
YoY Change -17.59% 1.71% 10.49%
Cash & Equivalents $4.019B $5.319B $6.598B
Short-Term Investments $1.666B $1.581B $187.0M
Other Short-Term Assets $822.0M $790.0M $1.178B
YoY Change 1.11% -32.94% -20.94%
Inventory $2.644B $2.553B $2.513B
Prepaid Expenses $822.3M $790.1M
Receivables $3.336B $3.268B $3.533B
Other Receivables $552.0M $528.0M $565.0M
Total Short-Term Assets $13.04B $14.04B $14.57B
YoY Change -8.49% -3.66% 2.74%
LONG-TERM ASSETS
Property, Plant & Equipment $7.760B $7.639B $7.812B
YoY Change 0.0% -2.22% -1.64%
Goodwill $1.501B
YoY Change 4.64%
Intangibles
YoY Change
Long-Term Investments $6.313B $5.224B $3.220B
YoY Change 56.65% 62.24% 140.3%
Other Assets $2.533B $2.388B $2.216B
YoY Change 1.6% 7.75% 4.09%
Total Long-Term Assets $13.60B $12.64B $18.47B
YoY Change 16.73% -31.54% 17.49%
TOTAL ASSETS
Total Short-Term Assets $13.04B $14.04B $14.57B
Total Long-Term Assets $13.60B $12.64B $18.47B
Total Assets $34.40B $34.32B $33.04B
YoY Change 2.2% 3.87% 10.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.188B $1.329B $1.154B
YoY Change 5.61% 15.14% 11.5%
Accrued Expenses $940.0M $773.0M $689.0M
YoY Change 16.77% 12.19% -8.01%
Deferred Revenue
YoY Change
Short-Term Debt $11.90M $9.100M $1.629B
YoY Change -99.22% -99.44% 950.97%
Long-Term Debt Due $11.90M
YoY Change -99.22%
Total Short-Term Liabilities $8.390B $6.961B $8.219B
YoY Change -6.06% -15.31% 34.8%
LONG-TERM LIABILITIES
Long-Term Debt $5.519B $5.511B $5.451B
YoY Change 1.0% 1.1% -21.93%
Other Long-Term Liabilities $1.369B $1.815B $4.314B
YoY Change -12.99% -57.93% -0.48%
Total Long-Term Liabilities $11.24B $11.30B $9.765B
YoY Change 0.38% 15.75% -13.71%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.390B $6.961B $8.219B
Total Long-Term Liabilities $11.24B $11.30B $9.765B
Total Liabilities $19.63B $18.26B $17.98B
YoY Change -2.48% 1.57% 2.81%
SHAREHOLDERS EQUITY
Retained Earnings $16.09B $17.06B
YoY Change 7.99%
Common Stock $5.680B $5.646B
YoY Change 1.23%
Preferred Stock
YoY Change
Treasury Stock (at cost) $192.4M $94.30M
YoY Change 101.89%
Treasury Stock Shares 2.850M shares
Shareholders Equity $14.77B $16.07B $15.06B
YoY Change
Total Liabilities & Shareholders Equity $34.40B $34.32B $33.04B
YoY Change 2.2% 3.87% 10.49%

Cashflow Statement

Concept 2012 Q4 2012 Q3 2011 Q3
OPERATING ACTIVITIES
Net Income $827.2M $1.327B $1.236B
YoY Change -3.61% 7.3% -5.11%
Depreciation, Depletion And Amortization $344.6M $369.7M $358.2M
YoY Change 8.06% 3.21% 3.92%
Cash From Operating Activities $1.602B $1.544B $2.073B
YoY Change -17.62% -25.52% 17.87%
INVESTING ACTIVITIES
Capital Expenditures -$450.0M -$284.0M -$348.6M
YoY Change 58.95% -18.53% 90.39%
Acquisitions
YoY Change
Other Investing Activities -$1.213B $151.3M -$659.7M
YoY Change -23.92% -122.93% 8.97%
Cash From Investing Activities -$1.663B -$132.7M -$1.008B
YoY Change -11.42% -86.84% 27.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.265B -544.7M -440.9M
YoY Change 94.38% 23.54% 11.96%
NET CHANGE
Cash From Operating Activities 1.602B 1.544B 2.073B
Cash From Investing Activities -1.663B -132.7M -1.008B
Cash From Financing Activities -1.265B -544.7M -440.9M
Net Change In Cash -1.326B 866.9M 624.2M
YoY Change 127.39% 38.88% 8.22%
FREE CASH FLOW
Cash From Operating Activities $1.602B $1.544B $2.073B
Capital Expenditures -$450.0M -$284.0M -$348.6M
Free Cash Flow $2.052B $1.828B $2.422B
YoY Change -7.89% -24.51% 24.7%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.47
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.47
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
3.13
CY2012Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
527300000 USD
CY2011Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
640200000 USD
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1125200000 USD
CY2012Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1328700000 USD
CY2011Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3597700000 USD
CY2012Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3268200000 USD
CY2011Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
261600000 USD
CY2012Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
338200000 USD
CY2011Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
1086300000 USD
CY2012Q3 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
1275100000 USD
CY2011Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6833700000 USD
CY2012Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7305500000 USD
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3858600000 USD
CY2012Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3535900000 USD
CY2011Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4886800000 USD
CY2012Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4919900000 USD
CY2012Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
34400000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
110700000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
100300000 USD
CY2011Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
36500000 USD
CY2011Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
110100000 USD
CY2012Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
111000000 USD
CY2011Q4 us-gaap Assets
Assets
33659800000 USD
CY2012Q3 us-gaap Assets
Assets
34321000000 USD
CY2012Q3 us-gaap Assets Current
AssetsCurrent
14038900000 USD
CY2011Q4 us-gaap Assets Current
AssetsCurrent
14248200000 USD
CY2012Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
12643200000 USD
CY2011Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
11651300000 USD
CY2012Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
942300000 USD
CY2011Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
2164400000 USD
CY2012Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
5440000000 USD
us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
113600000 USD
CY2011Q3 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
25600000 USD
CY2012Q3 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
43100000 USD
us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
70000000 USD
CY2011Q3 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
2500000 USD
us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
7600000 USD
us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
7400000 USD
CY2012Q3 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
2200000 USD
CY2012Q3 us-gaap Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
34700000 USD
CY2011Q4 us-gaap Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
80000000 USD
CY2012Q3 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
150600000 USD
CY2011Q4 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
103000000 USD
CY2012Q3 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Other Percentage Of Nonperforming Assets
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureOtherPercentageOfNonperformingAssets
0.85
CY2012Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability
50000000 USD
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5319200000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5922500000 USD
CY2011Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6597700000 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5993200000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
604500000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-603300000 USD
CY2012Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.49
CY2011Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.49
CY2011Q4 us-gaap Common Stock Shares Held In Employee Trust
CommonStockSharesHeldInEmployeeTrust
3013100000 USD
CY2012Q3 us-gaap Common Stock Shares Held In Employee Trust
CommonStockSharesHeldInEmployeeTrust
3013200000 USD
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
724100000 USD
CY2012Q3 us-gaap Common Stock Value
CommonStockValue
725800000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3653700000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3584000000 USD
CY2011Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
740300000 USD
CY2012Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1724900000 USD
CY2011Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1338100000 USD
CY2012Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1203600000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
3548200000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
3746200000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1054700000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1117600000 USD
CY2011Q3 us-gaap Derivative Instruments Gain Loss Recognized In Income Net
DerivativeInstrumentsGainLossRecognizedInIncomeNet
-51700000 USD
CY2012Q3 us-gaap Derivative Instruments Gain Loss Recognized In Income Net
DerivativeInstrumentsGainLossRecognizedInIncomeNet
-23700000 USD
us-gaap Derivative Instruments Gain Loss Recognized In Income Net
DerivativeInstrumentsGainLossRecognizedInIncomeNet
-38500000 USD
us-gaap Derivative Instruments Gain Loss Recognized In Income Net
DerivativeInstrumentsGainLossRecognizedInIncomeNet
-1000000 USD
CY2011Q3 us-gaap Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet
15500000 USD
us-gaap Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet
0 USD
us-gaap Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet
41200000 USD
CY2012Q3 us-gaap Derivative Instruments Loss Reclassified From Accumulated Oci Into Income Effective Portion
DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
2300000 USD
CY2011Q3 us-gaap Derivative Instruments Loss Reclassified From Accumulated Oci Into Income Effective Portion
DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
2300000 USD
us-gaap Derivative Instruments Loss Reclassified From Accumulated Oci Into Income Effective Portion
DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
6700000 USD
us-gaap Derivative Instruments Loss Reclassified From Accumulated Oci Into Income Effective Portion
DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
6700000 USD
CY2011Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
542300000 USD
CY2012Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
0 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
2.92
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
1.18
CY2011Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
1.11
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
18600000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-18700000 USD
CY2011Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
804700000 USD
CY2012Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
772700000 USD
us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
787800000 USD
us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
0 USD
CY2011Q3 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
0 USD
CY2012Q3 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
787800000 USD
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
-151000000 USD
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
-16000000 USD
us-gaap Impairment Of Investments
ImpairmentOfInvestments
17900000 USD
CY2012Q3 us-gaap Impairment Of Investments
ImpairmentOfInvestments
800000 USD
CY2011Q3 us-gaap Impairment Of Investments
ImpairmentOfInvestments
10900000 USD
us-gaap Impairment Of Investments
ImpairmentOfInvestments
8200000 USD
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1874700000 USD
CY2011Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1502500000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4307700000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4395700000 USD
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
548100000 USD
CY2011Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
266200000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1134400000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
818200000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-222000000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-206200000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-76700000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
271500000 USD
CY2011Q3 us-gaap Interest Expense
InterestExpense
45000000 USD
us-gaap Interest Expense
InterestExpense
135300000 USD
CY2012Q3 us-gaap Interest Expense
InterestExpense
47000000 USD
us-gaap Interest Expense
InterestExpense
135900000 USD
CY2012Q3 us-gaap Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net
InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
9000000 USD
CY2011Q4 us-gaap Inventory Net
InventoryNet
2299800000 USD
CY2012Q3 us-gaap Inventory Net
InventoryNet
2553400000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
79000000 USD
CY2012Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
25700000 USD
CY2011Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
22200000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
55500000 USD
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
33659800000 USD
CY2012Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
34321000000 USD
CY2012Q3 us-gaap Liabilities Current
LiabilitiesCurrent
6960700000 USD
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8930900000 USD
CY2012Q3 us-gaap Liabilities Fair Value Disclosure Nonrecurring
LiabilitiesFairValueDisclosureNonrecurring
66900000 USD
CY2011Q4 us-gaap Liabilities Fair Value Disclosure Nonrecurring
LiabilitiesFairValueDisclosureNonrecurring
121600000 USD
CY2012Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
11303400000 USD
CY2011Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
11193300000 USD
CY2012Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5510900000 USD
CY2011Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5464700000 USD
CY2012Q3 us-gaap Long Term Debt Percentage Bearing Fixed Interest Rate
LongTermDebtPercentageBearingFixedInterestRate
1.00
CY2012Q3 us-gaap Long Term Investments
LongTermInvestments
5224300000 USD
CY2011Q4 us-gaap Long Term Investments
LongTermInvestments
4029800000 USD
us-gaap Maximum Remaining Maturity Of Foreign Currency Derivatives1
MaximumRemainingMaturityOfForeignCurrencyDerivatives1
P30D
CY2012Q3 us-gaap Minority Interest
MinorityInterest
-7600000 USD
CY2011Q4 us-gaap Minority Interest
MinorityInterest
-6100000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1719000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3154400000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2947600000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1170300000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5289800000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3702800000 USD
us-gaap Net Income Loss
NetIncomeLoss
3489500000 USD
CY2011Q3 us-gaap Net Income Loss
NetIncomeLoss
1236300000 USD
us-gaap Net Income Loss
NetIncomeLoss
3261300000 USD
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
1326600000 USD
CY2011Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-83400000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
726000000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-152200000 USD
CY2012Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
788500000 USD
CY2011Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2493400000 USD
CY2012Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2387800000 USD
CY2012Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
398300000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
322700000 USD
CY2011Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-496000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
164200000 USD
CY2011Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2903500000 USD
CY2012Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2816400000 USD
CY2011Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1573800000 USD
CY2012Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1815000000 USD
CY2011Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-60600000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-71800000 USD
CY2012Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
22000000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5500000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
60700000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-67000000 USD
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
475500000 USD
CY2011Q3 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
176200000 USD
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
491800000 USD
CY2012Q3 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
142100000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
33300000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
61800000 USD
us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
492200000 USD
us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
416100000 USD
us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
-545000000 USD
us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
-257300000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
1636200000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
1639200000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
307800000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
199300000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
102000000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
605700000 USD
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
2659300000 USD
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
5506800000 USD
CY2012Q3 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
2702400000 USD
CY2011Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
3068500000 USD
CY2011Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
813400000 USD
CY2012Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
790100000 USD
us-gaap Proceeds From Payments For Long Term Loans For Related Parties
ProceedsFromPaymentsForLongTermLoansForRelatedParties
165000000 USD
us-gaap Proceeds From Payments For Long Term Loans For Related Parties
ProceedsFromPaymentsForLongTermLoansForRelatedParties
-165000000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
400000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-28600000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-15200000 USD
CY2011Q3 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
775700000 USD
CY2012Q3 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
1698800000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
1274200000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
5334100000 USD
us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
1082600000 USD
us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
3557400000 USD
us-gaap Proceeds From Sale Of Intangible Assets
ProceedsFromSaleOfIntangibleAssets
1212100000 USD
us-gaap Proceeds From Sale Of Intangible Assets
ProceedsFromSaleOfIntangibleAssets
0 USD
CY2012Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14944400000 USD
CY2011Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14594000000 USD
CY2012Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7638900000 USD
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7760300000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1500000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
54600000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3665500000 USD
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1342800000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3815000000 USD
CY2011Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1280900000 USD
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
233800000 USD
CY2011Q3 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
25200000 USD
CY2012Q3 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
53300000 USD
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
77100000 USD
CY2012Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
17062200000 USD
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
14897800000 USD
CY2011Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
5971700000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
17748100000 USD
us-gaap Revenues
Revenues
16646000000 USD
CY2011Q3 us-gaap Revenues
Revenues
6147900000 USD
CY2012Q3 us-gaap Revenues
Revenues
5443300000 USD
us-gaap Revenues
Revenues
18239900000 USD
CY2012Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
5301200000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
16170500000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5536000000 USD
CY2011Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1917800000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5746500000 USD
CY2012Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1757400000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
110700000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
100300000 USD
CY2012Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
9100000 USD
CY2011Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
1522300000 USD
CY2012Q3 us-gaap Short Term Investments
ShortTermInvestments
1580700000 USD
CY2011Q4 us-gaap Short Term Investments
ShortTermInvestments
974600000 USD
CY2000 us-gaap Stock Repurchase Program Authorized Amount
StockRepurchaseProgramAuthorizedAmount
3000000000 USD
us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount
419200000 USD
CY2012Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
16056900000 USD
CY2011Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
13535600000 USD
CY2012Q3 us-gaap Treasury Stock Value
TreasuryStockValue
94300000 USD
CY2011Q4 us-gaap Treasury Stock Value
TreasuryStockValue
95300000 USD
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
0 USD
CY2011Q3 lly Acquired In Process Research And Development
AcquiredInProcessResearchAndDevelopment
0 USD
CY2012Q3 lly Acquired In Process Research And Development
AcquiredInProcessResearchAndDevelopment
0 USD
lly Acquired In Process Research And Development
AcquiredInProcessResearchAndDevelopment
0 USD
lly Acquired In Process Research And Development
AcquiredInProcessResearchAndDevelopment
388000000 USD
lly Acquired In Process Research And Development Net Of Tax
AcquiredInProcessResearchAndDevelopmentNetOfTax
252200000 USD
lly Acquired In Process Research And Development Net Of Tax
AcquiredInProcessResearchAndDevelopmentNetOfTax
0 USD
lly Acquisitions Text Block New
AcquisitionsTextBlockNew
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Note 3: Acquisitions</font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On February&#160;17, 2012, we acquired all of the outstanding stock of ChemGen Corporation, a privately-held bioscience company specializing in the development and commercialization of innovative feed-enzyme products that improve the efficiency of poultry, egg, and meat production, for total purchase consideration of </font><font style="font-family:Arial;font-size:10pt;color:#000000;text-decoration:none;">$206.9 million</font><font style="font-family:Arial;font-size:10pt;"> in cash. In connection with this acquisition, we preliminarily recorded </font><font style="font-family:Arial;font-size:10pt;color:#000000;text-decoration:none;">$151.5 million</font><font style="font-family:Arial;font-size:10pt;"> of marketed product assets, with </font><font style="font-family:Arial;font-size:10pt;color:#000000;text-decoration:none;">$55.4 million</font><font style="font-family:Arial;font-size:10pt;"> of other net assets. The final determination may result in asset and liability fair values that differ from the preliminary estimates, but it is not expected that these differences will be material to our consolidated financial statements.</font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On July&#160;7, 2011, we acquired the animal health business of Janssen Pharmaceutica NV, a Johnson&#160;&amp; Johnson company, for total purchase consideration of </font><font style="font-family:Arial;font-size:10pt;color:#000000;text-decoration:none;">$307.8 million</font><font style="font-family:Arial;font-size:10pt;"> in cash. We obtained a portfolio of more than </font><font style="font-family:Arial;font-size:10pt;color:#000000;text-decoration:none;">50</font><font style="font-family:Arial;font-size:10pt;">&#160;animal health products. In connection with this acquisition, we recorded </font><font style="font-family:Arial;font-size:10pt;color:#000000;text-decoration:none;">$234.4 million</font><font style="font-family:Arial;font-size:10pt;"> of marketed product assets and </font><font style="font-family:Arial;font-size:10pt;color:#000000;text-decoration:none;">$29.6 million</font><font style="font-family:Arial;font-size:10pt;"> of acquired in-process research and development (IPR&amp;D) assets, with </font><font style="font-family:Arial;font-size:10pt;color:#000000;text-decoration:none;">$43.8&#160;million</font><font style="font-family:Arial;font-size:10pt;"> of other net assets.</font></div></div>
CY2011Q4 lly Available For Sale Securities Continuous Unrealized Gain Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedGainPositionFairValue
2498900000 USD
CY2012Q3 lly Available For Sale Securities Continuous Unrealized Gain Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedGainPositionFairValue
5050600000 USD
lly Collaborative Arrangement Income Statement Classification And Amounts
CollaborativeArrangementIncomeStatementClassificationAndAmounts
211000000 USD
CY2012Q3 lly Collaborative Arrangement Income Statement Classification And Amounts
CollaborativeArrangementIncomeStatementClassificationAndAmounts
65200000 USD
CY2011Q3 lly Collaborative Arrangement Income Statement Classification And Amounts
CollaborativeArrangementIncomeStatementClassificationAndAmounts
58600000 USD
lly Collaborative Arrangement Income Statement Classification And Amounts
CollaborativeArrangementIncomeStatementClassificationAndAmounts
155500000 USD
lly Cost Of Sales Operating Expenses And Other Net
CostOfSalesOperatingExpensesAndOtherNet
13932200000 USD
lly Cost Of Sales Operating Expenses And Other Net
CostOfSalesOperatingExpensesAndOtherNet
12250300000 USD
CY2012Q3 lly Cost Of Sales Operating Expenses And Other Net
CostOfSalesOperatingExpensesAndOtherNet
3568600000 USD
CY2011Q3 lly Cost Of Sales Operating Expenses And Other Net
CostOfSalesOperatingExpensesAndOtherNet
4645400000 USD
CY2012Q3 lly Description Of Derivative Activity Volume Percent
DescriptionOfDerivativeActivityVolumePercent
0.60
CY2012Q3 lly Goodwill And Other Intangibles Net
GoodwillAndOtherIntangiblesNet
5031100000 USD
CY2011Q4 lly Goodwill And Other Intangibles Net
GoodwillAndOtherIntangiblesNet
5128100000 USD
lly Purchased In Process Research And Development
PurchasedInProcessResearchAndDevelopment
0 USD
lly Purchased In Process Research And Development
PurchasedInProcessResearchAndDevelopment
388000000 USD
CY2011Q4 lly Sales Rebates And Discounts
SalesRebatesAndDiscounts
1771300000 USD
CY2012Q3 lly Sales Rebates And Discounts
SalesRebatesAndDiscounts
1695600000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
dei Document Period End Date
DocumentPeriodEndDate
2012-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000059478
CY2012Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1160452507 shares
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
Lilly Eli & Co
dei Entity Voluntary Filers
EntityVoluntaryFilers
No
dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes

Files In Submission

Name View Source Status
0000059478-12-000021-index-headers.html Edgar Link pending
0000059478-12-000021-index.html Edgar Link pending
0000059478-12-000021.txt Edgar Link pending
0000059478-12-000021-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
lly-20120930.xml Edgar Link completed
lly-20120930.xsd Edgar Link pending
lly-20120930_cal.xml Edgar Link unprocessable
lly-20120930_def.xml Edgar Link unprocessable
lly-20120930_lab.xml Edgar Link unprocessable
lly-20120930_pre.xml Edgar Link unprocessable
lly-9302012x10q.htm Edgar Link pending
lly-930x2012x10qxexhibit10.htm Edgar Link pending
lly-930x2012x10qxexhibit11.htm Edgar Link pending
lly-930x2012x10qxexhibit12.htm Edgar Link pending
lly-930x2012x10qxexhibit311.htm Edgar Link pending
lly-930x2012x10qxexhibit32.htm Edgar Link pending
lly-9x30x2012x10qxexhibit312.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending